Body Weight Support Harness System in Spinal Muscular Atrophy
Exploring the Feasibility and Utility of In-home Body Weight Support Harness System Use in Children Treated for Spinal Muscular Atrophy: a Pilot Study
1 other identifier
interventional
33
1 country
1
Brief Summary
The goal of this pilot interventional study is to learn about the use of an in-home harness system in children who have been treated for spinal muscular atrophy. The main questions it aims to answer are:
- 1.Is the in-home body weight support harness system a feasible option for families to use?
- 2.Is the in-home body weight support harness system a useful tool for children treated for spinal muscular atrophy?
- 3.Is the in-home body weight support harness system a safe tool for children treated for spinal muscular atrophy?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2020
CompletedFirst Submitted
Initial submission to the registry
January 20, 2023
CompletedFirst Posted
Study publicly available on registry
February 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2024
CompletedJuly 22, 2024
July 1, 2024
1.8 years
January 20, 2023
July 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Caregiver survey
A five question likert-style survey asking families to rate their experience during the study. The scales asks the family to rate (1) the perceived impact of BWSS on motor and (2) non-motor skills, (3) the child's perceived enjoyment using the system, (4) the ease of equipment use, and (5) if the family believed that use of the BWSS was beneficial on a 5-point Likert scale; scores of 4 or 5 were considered favorable, scores of 3 were considered neutral, and scores of 1 or 2 were considered unfavorable. Higher scores indicate greater perceived benefit of participation.
End of study visit (month 6)
Change in The Neuromuscular Gross Motor Outcome (GRO) scale
A 50-item performance-based outcome developed to quantify motor function across the span of age and abilities in individuals with neuromuscular disorders including spinal muscular atrophy (SMA). Scores range from 0 - 100 points; higher scores reflect a greater level of function. An increase in score indicates a better outcome.
Completed at baseline, 3 months, and 6 months
Change in Hammersmith Functional Motor Scale Expanded (HFMSE)
A disease-specific and performance-based outcomes originally developed to measure motor skill in untreated individuals with SMA. Scores range from 0 - 66 points; higher scores reflect a greater level of function. An increase in score indicates a better outcome.
Completed at baseline, 3 months, and 6 months
Change in Revised Hammersmith Scale (RHS)
A disease-specific and performance-based outcomes originally developed to measure motor skill in untreated individuals with SMA, revised following Rasch analysis of HFMSE. Scores range from 0 - 69 points; higher scores reflect a greater level of function. An increase in score indicates a better outcome.
Completed at baseline, 3 months, and 6 months
Change in Bayley Scales of Infant and Toddler Development 3rd ed. (Bayley-III), Gross motor subtest
A norm-referenced developmental assessment of gross motor skill in children 16 days - 3.5 years of age. Raw scores range from 0 - 72. Higher scores indicate a greater level of funcion. An increase in score indicates a better outcome.
Completed at baseline, 3 months, and 6 months
Change in World Health Organization Motor Milestone Checklist
A checklist of key gross motor milestones expected during typical development. Scores can range from 0 - 6 milestones achieved. Achievement of a greater number of milestones indicates better outcomes.
Completed at baseline, 3 months, and 6 months
Secondary Outcomes (1)
Harness use log
Completed throughout 6-month study period
Study Arms (1)
In-home body weight support harness system
EXPERIMENTALAll participants will be entered into treatment arm and receive an in-home body weight support harness system
Interventions
A portable, adjustable body weight support harness system that occupies roughly 9 feet x 9 feet space in the home. The system allows 360 degrees of mobility anywhere within the footprint of the frame. The amount of body weight support is adjustable.
Eligibility Criteria
You may qualify if:
- Confirmed heterozygous mutation in SMN1 gene and 2 or 3 copies of SMN2 (historically, SMA Type 1 and Type 2)
- Past or current treatment with nusinersen, onasemnogene abeparvovec, or risdiplam
- Upright head control (defined as the ability to lift head from full forward flexion)
- Weight under or 50lbs
- Confirmed motor delay
You may not qualify if:
- + copies of SMN2 (historically, SMA Type 3 and 4)
- Evidence of lower limb injury or recent fracture
- In the opinion of the investigator, it was unsafe for the child to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nationwide Children's Hospitallead
- Novartiscollaborator
Study Sites (1)
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Related Publications (1)
Iammarino MA, Alfano LN, Reash NF, Sabo B, Conroy S, Noritz G, Wendland M, Lowes LP. Feasibility and utility of in-home body weight support harness system use in young children treated for spinal muscular atrophy: A single-arm prospective cohort study. PLoS One. 2024 Mar 19;19(3):e0300244. doi: 10.1371/journal.pone.0300244. eCollection 2024.
PMID: 38502672DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Megan A Iammarino, DPT
Nationwide Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Outcomes assessors are masked to previous participant performance.
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Physical Therapist
Study Record Dates
First Submitted
January 20, 2023
First Posted
February 8, 2023
Study Start
September 7, 2018
Primary Completion
June 15, 2020
Study Completion
July 15, 2024
Last Updated
July 22, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
Participant data will be provided in summary form at manuscript submission. Certain individual participant data will be available in manuscript as well.